These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
247 related items for PubMed ID: 18474648
1. Interaction of Porphyromonas gingivalis with oral streptococci requires a motif that resembles the eukaryotic nuclear receptor box protein-protein interaction domain. Daep CA, Lamont RJ, Demuth DR. Infect Immun; 2008 Jul; 76(7):3273-80. PubMed ID: 18474648 [Abstract] [Full Text] [Related]
2. Structural characterization of peptide-mediated inhibition of Porphyromonas gingivalis biofilm formation. Daep CA, James DM, Lamont RJ, Demuth DR. Infect Immun; 2006 Oct; 74(10):5756-62. PubMed ID: 16988253 [Abstract] [Full Text] [Related]
3. Role of the Streptococcus gordonii SspB protein in the development of Porphyromonas gingivalis biofilms on streptococcal substrates. Lamont RJ, El-Sabaeny A, Park Y, Cook GS, Costerton JW, Demuth DR. Microbiology (Reading); 2002 Jun; 148(Pt 6):1627-1636. PubMed ID: 12055284 [Abstract] [Full Text] [Related]
4. Structural dissection and in vivo effectiveness of a peptide inhibitor of Porphyromonas gingivalis adherence to Streptococcus gordonii. Daep CA, Novak EA, Lamont RJ, Demuth DR. Infect Immun; 2011 Jan; 79(1):67-74. PubMed ID: 21041492 [Abstract] [Full Text] [Related]
5. Identification of functional domains of the minor fimbrial antigen involved in the interaction of Porphyromonas gingivalis with oral streptococci. Roky M, Trent JO, Demuth DR. Mol Oral Microbiol; 2020 Apr; 35(2):66-77. PubMed ID: 31994329 [Abstract] [Full Text] [Related]
6. Tobacco smoke augments Porphyromonas gingivalis-Streptococcus gordonii biofilm formation. Bagaitkar J, Daep CA, Patel CK, Renaud DE, Demuth DR, Scott DA. PLoS One; 2011 Apr; 6(11):e27386. PubMed ID: 22110637 [Abstract] [Full Text] [Related]
7. BAR-encapsulated nanoparticles for the inhibition and disruption of Porphyromonas gingivalis-Streptococcus gordonii biofilms. Mahmoud MY, Demuth DR, Steinbach-Rankins JM. J Nanobiotechnology; 2018 Sep 15; 16(1):69. PubMed ID: 30219060 [Abstract] [Full Text] [Related]
8. Peptide-modified nanoparticles inhibit formation of Porphyromonas gingivalis biofilms with Streptococcus gordonii. Kalia P, Jain A, Radha Krishnan R, Demuth DR, Steinbach-Rankins JM. Int J Nanomedicine; 2017 Sep 15; 12():4553-4562. PubMed ID: 28790818 [Abstract] [Full Text] [Related]
9. Identification of the binding domain of Streptococcus oralis glyceraldehyde-3-phosphate dehydrogenase for Porphyromonas gingivalis major fimbriae. Nagata H, Iwasaki M, Maeda K, Kuboniwa M, Hashino E, Toe M, Minamino N, Kuwahara H, Shizukuishi S. Infect Immun; 2009 Nov 15; 77(11):5130-8. PubMed ID: 19737900 [Abstract] [Full Text] [Related]
10. Discrete protein determinant directs the species-specific adherence of Porphyromonas gingivalis to oral streptococci. Demuth DR, Irvine DC, Costerton JW, Cook GS, Lamont RJ. Infect Immun; 2001 Sep 15; 69(9):5736-41. PubMed ID: 11500450 [Abstract] [Full Text] [Related]
11. Identification of Small-Molecule Inhibitors Targeting Porphyromonas gingivalis Interspecies Adherence and Determination of Their In Vitro and In Vivo Efficacies. Roky M, Tan J, Sztukowska MN, Trent JO, Demuth DR. Antimicrob Agents Chemother; 2020 Oct 20; 64(11):. PubMed ID: 32816725 [Abstract] [Full Text] [Related]
12. Short fimbriae of Porphyromonas gingivalis and their role in coadhesion with Streptococcus gordonii. Park Y, Simionato MR, Sekiya K, Murakami Y, James D, Chen W, Hackett M, Yoshimura F, Demuth DR, Lamont RJ. Infect Immun; 2005 Jul 20; 73(7):3983-9. PubMed ID: 15972485 [Abstract] [Full Text] [Related]
13. Selective substitution of amino acids limits proteolytic cleavage and improves the bioactivity of an anti-biofilm peptide that targets the periodontal pathogen, Porphyromonas gingivalis. Daep CA, Novak EA, Lamont RJ, Demuth DR. Peptides; 2010 Dec 20; 31(12):2173-8. PubMed ID: 20800634 [Abstract] [Full Text] [Related]
14. Mfa4, an Accessory Protein of Mfa1 Fimbriae, Modulates Fimbrial Biogenesis, Cell Auto-Aggregation, and Biofilm Formation in Porphyromonas gingivalis. Ikai R, Hasegawa Y, Izumigawa M, Nagano K, Yoshida Y, Kitai N, Lamont RJ, Yoshimura F, Murakami Y. PLoS One; 2015 Dec 20; 10(10):e0139454. PubMed ID: 26437277 [Abstract] [Full Text] [Related]
15. Identification of a Streptococcus gordonii SspB domain that mediates adhesion to Porphyromonas gingivalis. Brooks W, Demuth DR, Gil S, Lamont RJ. Infect Immun; 1997 Sep 20; 65(9):3753-8. PubMed ID: 9284148 [Abstract] [Full Text] [Related]
16. Maturation of the Mfa1 Fimbriae in the Oral Pathogen Porphyromonas gingivalis. Lee JY, Miller DP, Wu L, Casella CR, Hasegawa Y, Lamont RJ. Front Cell Infect Microbiol; 2018 Sep 20; 8():137. PubMed ID: 29868494 [Abstract] [Full Text] [Related]
17. Targeting the HUβ Protein Prevents Porphyromonas gingivalis from Entering into Preexisting Biofilms. Rocco CJ, Bakaletz LO, Goodman SD. J Bacteriol; 2018 Jun 01; 200(11):. PubMed ID: 29437850 [Abstract] [Full Text] [Related]
18. A streptococcal effector protein that inhibits Porphyromonas gingivalis biofilm development. Christopher AB, Arndt A, Cugini C, Davey ME. Microbiology (Reading); 2010 Nov 01; 156(Pt 11):3469-3477. PubMed ID: 20705665 [Abstract] [Full Text] [Related]
19. Expression of the short fimbriae of Porphyromonas gingivalis is regulated in oral bacterial consortia. Park Y, James CE, Yoshimura F, Lamont RJ. FEMS Microbiol Lett; 2006 Sep 01; 262(1):65-71. PubMed ID: 16907740 [Abstract] [Full Text] [Related]
20. In Vitro and In Vivo Activity of Peptidomimetic Compounds That Target the Periodontal Pathogen Porphyromonas gingivalis. Tan J, Patil PC, Luzzio FA, Demuth DR. Antimicrob Agents Chemother; 2018 Jul 01; 62(7):. PubMed ID: 29760142 [Abstract] [Full Text] [Related] Page: [Next] [New Search]